Success Metrics

Clinical Success Rate
94.9%

Based on 37 completed trials

Completion Rate
95%(37/39)
Active Trials
2(4%)
Results Posted
5%(2 trials)
Terminated
2(4%)

Phase Distribution

Ph not_applicable
14
26%
Ph phase_3
7
13%
Ph phase_2
3
6%

Phase Distribution

0

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution24 total trials
Phase 2Efficacy & side effects
3(12.5%)
Phase 3Large-scale testing
7(29.2%)
N/ANon-phased studies
14(58.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.1%

37 of 42 finished

Non-Completion Rate

11.9%

5 ended early

Currently Active

2

trials recruiting

Total Trials

54

all time

Status Distribution
Active(2)
Completed(37)
Terminated(5)
Other(10)

Detailed Status

Completed37
unknown10
Withdrawn3
Active, not recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
54
Active
2
Success Rate
94.9%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (12.5%)
Phase 37 (29.2%)
N/A14 (58.3%)

Trials by Status

active_not_recruiting24%
withdrawn36%
completed3769%
terminated24%
unknown1019%

Recent Activity

Clinical Trials (54)

Showing 20 of 54 trialsScroll for more
NCT00819208Not Applicable

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Completed
NCT00514254

Risk Factors for Endometrial Cancer in Black Women

Active Not Recruiting
NCT00609791Phase 2

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Active Not Recruiting
NCT01445275

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Withdrawn
NCT01344837

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Completed
NCT01198171

Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer

Completed
NCT00666731

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Completed
NCT00661882

Pancreatic Cancer Collaborative Registry

Completed
NCT00740961

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

Terminated
NCT00268528

Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission

Completed
NCT00478010Not Applicable

Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer

Completed
NCT00897273

Oral HPV Infection in Young Men

Completed
NCT00383279Not Applicable

Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer

Completed
NCT00665782

Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

Completed
NCT00755313

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Completed
NCT00675636

Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer

Completed
NCT00483288Not Applicable

Written Educational Information and Phone Calls in Increasing Follow-Up Care in Hispanic Women With Abnormal Pap Smears

Completed
NCT01321385

Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia

Completed
NCT00898482

Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Completed
NCT00268502

Quality of Life in African-American or Caucasian Female Breast Cancer Survivors

Completed

Drug Details

Intervention Type
OTHER
Total Trials
54